Atozet 10 mg/10 mg Film-Coated Tablets is a powerful lipid-modifying combination therapy manufactured by the global pharmaceutical company Organon. Formulated with two complementary active ingredients — Ezetimibe and Atorvastatin — Atozet provides dual inhibition of cholesterol absorption in the intestine and cholesterol synthesis in the liver, significantly lowering LDL cholesterol and cardiovascular risks.

Indications: Atozet 10 mg/10 mg is used for:

• Treatment of primary (familial and non-familial) hypercholesterolemia

• Reducing elevated levels of total cholesterol, LDL-C, Apo B, and triglycerides

• Increasing HDL-C (“good” cholesterol) levels in patients with hyperlipidemia

• Reducing the risk of cardiovascular events (heart attack, stroke, revascularization) in patients with coronary heart disease (CHD)

• Patients not adequately controlled with statin monotherapy alone

Reasons for Use:

• Elevated cholesterol levels resistant to diet and lifestyle modifications

• High risk for developing atherosclerosis, myocardial infarction, or stroke

• Need for dual-mechanism lipid reduction (intestinal + hepatic pathways)

• Prescribed by cardiologists to achieve strict target LDL-C goals

Key Features:

• Dual active ingredients: Ezetimibe 10 mg and Atorvastatin 10 mg

• Dual-action mechanism: Ezetimibe inhibits intestinal cholesterol absorption while Atorvastatin inhibits hepatic cholesterol synthesis

• Delivers robust and sustained reductions in LDL-C levels

• Convenient once-daily dosing regimen

• Pack of 30 film-coated tablets produced under strict global quality standards by Organon

Dosage Form: Atozet — Film-coated tablets, 10 mg / 10 mg (pack of 30 tablets)

Manufacturer: Organon

Active Ingredients:

• Ezetimibe — 10 mg

• Atorvastatin — 10 mg

#Atozet #Ezetimibe #Atorvastatin #Organon #CholesterolLowering #HeartHealth #LipidControl #Cardiology #IsraeliMeds #PharmacyIsrael